Cambrium from Germany secures €8M to drive Transition toward Bio-Based Economy using Molecular Design Technology
Berlin's synthetic biology startup Cambrium declared its success in securing €8M in a seed funding round. The investment was spearheaded by Essential Capital and saw participation from SNR, Valor Equity Partners, and HOF Capital.

The best Articles in our Network

Previous
Next